Connection
Robert Scheinman to Recombinant Proteins
This is a "connection" page, showing publications Robert Scheinman has written about Recombinant Proteins.
|
|
Connection Strength |
|
 |
|
 |
|
0.149 |
|
|
|
-
Crowell CK, Qin Q, Grampp GE, Radcliffe RA, Rogers GN, Scheinman RI. Sodium butyrate alters erythropoietin glycosylation via multiple mechanisms. Biotechnol Bioeng. 2008 Jan 01; 99(1):201-13.
Score: 0.059
-
Crowell CK, Grampp GE, Rogers GN, Miller J, Scheinman RI. Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system. Biotechnol Bioeng. 2007 Feb 15; 96(3):538-49.
Score: 0.056
-
Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol. 1995 Feb; 15(2):943-53.
Score: 0.024
-
Spalding AC, Jotte RM, Scheinman RI, Geraci MW, Clarke P, Tyler KL, Johnson GL. TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene. 2002 Jan 10; 21(2):260-71.
Score: 0.010